- Home
- RDNT vs CRNX Comparison
RDNT vs CRNX Comparison
Compare RDNT & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDNT
- CRNX
- Stock Information
- Founded
- RDNT 1985
- CRNX 2008
- Country
- RDNT United States
- CRNX United States
- Employees
- RDNT N/A
- CRNX N/A
- Industry
- RDNT Medical Specialities
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- RDNT Health Care
- CRNX Health Care
- Exchange
- RDNT Nasdaq
- CRNX Nasdaq
- Market Cap
- RDNT 5.9B
- CRNX 5.3B
- IPO Year
- RDNT 1986
- CRNX 2018
- Fundamental
- Price
- RDNT $81.98
- CRNX $57.22
- Analyst Decision
- RDNT Strong Buy
- CRNX Strong Buy
- Analyst Count
- RDNT 4
- CRNX 10
- Target Price
- RDNT $74.75
- CRNX $73.70
- AVG Volume (30 Days)
- RDNT 590.7K
- CRNX 603.3K
- Earning Date
- RDNT 11-10-2024
- CRNX 11-12-2024
- Dividend Yield
- RDNT N/A
- CRNX N/A
- EPS Growth
- RDNT N/A
- CRNX N/A
- EPS
- RDNT N/A
- CRNX N/A
- Revenue
- RDNT $1,772,946,000.00
- CRNX $1,038,999.00
- Revenue This Year
- RDNT $12.83
- CRNX N/A
- Revenue Next Year
- RDNT $8.66
- CRNX $494.25
- P/E Ratio
- RDNT N/A
- CRNX N/A
- Revenue Growth
- RDNT 12.20
- CRNX N/A
- 52 Week Low
- RDNT $32.00
- CRNX $29.72
- 52 Week High
- RDNT $93.65
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- RDNT 66.81
- CRNX 46.63
- Support Level
- RDNT $77.34
- CRNX $52.85
- Resistance Level
- RDNT $93.65
- CRNX $62.53
- Average True Range (ATR)
- RDNT 3.22
- CRNX 2.52
- MACD
- RDNT 0.64
- CRNX -0.56
- Stochastic Oscillator
- RDNT 58.24
- CRNX 30.05
About RDNT RadNet Inc.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.